Sun, Shuping
Kapolowicz, Michelle R.
Richardson, Matthew
Metherate, Raju
Zeng, Fan-Gang
Funding for this research was provided by:
National Institutes of Health (1R01-AG067073, 2T32-DC010775)
Article History
Received: 15 February 2021
Accepted: 3 June 2021
First Online: 23 June 2021
Competing interests
: FGZ owns stock in Axonics, DiaNavi, Nurotron, Syntiant, Velox and Xense. The other authors declare no competing interests.